Rajavithi Hospital
Bangkok, Thailand
3 recruiting
Showing 1–15 of 15 trials
Recruiting
Phase 3
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche250 enrolled56 locationsNCT06847542
Recruiting
Phase 2Phase 3
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Non-small Cell Lung Cancer
BioNTech SE1,260 enrolled206 locationsNCT06712316
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Janssen Research & Development, LLC750 enrolled214 locationsNCT06807424
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Hoffmann-La Roche1,050 enrolled351 locationsNCT06065748
Recruiting
Phase 3
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Viatris Innovation GmbH420 enrolled216 locationsNCT05648500
Recruiting
Phase 3
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Non-small Cell Lung CancerAnaplastic Lymphoma Kinase-positive
Nuvalent Inc.450 enrolled137 locationsNCT06765109
Recruiting
Phase 3
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Myelodysplastic Syndromes
Takeda225 enrolled155 locationsNCT06499285
Recruiting
Phase 3
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment
Regeneron Pharmaceuticals190 enrolled69 locationsNCT05133531
Recruiting
Phase 3
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Breast Cancer
Celcuity Inc674 enrolled203 locationsNCT06757634
Recruiting
Not Applicable
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
-arterial diseaseAtherosclerosisPeripheral Artery Disease
Concept Medical Inc.279 enrolled20 locationsNCT04511234
Recruiting
Not Applicable
SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease
AtherosclerosisPeripheral Artery DiseaseArterial Disease of Legs
Concept Medical Inc.219 enrolled20 locationsNCT04511247
Recruiting
Phase 4
Optimising TREATment for Severe Gram-Negative Bacterial Infections
bloodstream infectionCarbapenem Resistant Bacterial InfectionMultidrug Resistance+2 more
National University of Singapore600 enrolled41 locationsNCT07004049
Recruiting
COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2
Atrial Fibrillation
Mahidol University4,000 enrolled33 locationsNCT06396299
Recruiting
Not Applicable
Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Glycol Regimen
ColonoscopyBowel Preparation Solution
Department of Medical Services Ministry of Public Health of Thailand360 enrolled1 locationNCT06436833
Recruiting
Not Applicable
Artificial Intelligence in the Detection of Right Sided Colonic Polyp in Different Operator Experience
Colon Polyp
Department of Medical Services Ministry of Public Health of Thailand240 enrolled1 locationNCT05990218